Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Browse
News
Browse
Subscribe

Conference News

ESMO 2019: Pembrolizumab shows promise in endometrial cancer

(25 Oct 2019)

ESMO 2019: New data from the TAILORx study on cohort with recurrence score 26-100 shows 93% cancer-free rate at 5 years

(02 Oct 2019)

ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men

(02 Oct 2019)

ESMO 2019: First targeted therapy for cholangiocarcinoma shows clinical benefit in phase III trial

(30 Sep 2019)

ESMO 2019: Targeted therapy slows progression of advanced prostate cancer

(30 Sep 2019)

ESMO 2019: Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer

(30 Sep 2019)

ESMO 2019: Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy

(30 Sep 2019)

ESMO 2019: New combination therapy offers bowel cancer patients extra treatment option

(30 Sep 2019)

ESMO 2019: Blood test can replace invasive biopsy for more patients with lung cancer

(30 Sep 2019)

ESMO 2019: Two studies show CDK4/6 inhibitors improve overall survival in advanced breast cancer

(29 Sep 2019)

View all articles from the past year >

follow us

Biosimilar Medicines Core Principles and Communication


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation